Closed Mainboard IPO MANIPALHEALTH

Manipal Health Enterprises IPO GMP & Allotment

Manipal Health Enterprises Limited is a healthcare service provider engaged in running and managing hospitals, clinics and diagnostic centres, primarily in India. It operates a network of multi-speciality hospitals offering clinical services across several specialities, with a focus on tertiary and quaternary care such as cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics and renal sciences. The company serves patients through inpatient and outpatient services, generating revenue from healthcare services paid by patients directly, insurance and third-party administrators, government schemes and corporate arrangements. Its network includes multiple hospitals supported by a large pool of doctors, and it caters to a significant volume of patients across its facilities. The company operates as a single business segment focused on medical and healthcare services, combining hospital infrastructure, clinical expertise and diagnostic capabilities to deliver care.

IPO Price Band
₹560.00 - ₹590.00
Lot Size
25 Shares
Bidding Closes
31 Jul 2026
Listing Date
05 Aug 2026
Will you apply for this IPO?
Is this GMP accurate?
Did you get allotted this IPO?
IPO Details

Complete IPO information

IPO Open Date 29 Jul 2026
IPO Close Date 31 Jul 2026
IPO Price Band ₹560.00 - ₹590.00
Lot Size 25 Shares
Current GMP ₹6
Estimated Listing Gain +1.02%
Issue Size -
Fresh Issue -
Issue Type Mainboard
IPO Listing NSE, BSE
Retail Quota TBA
Registrar TBA
Overall Subscription 4.92x
Minimum Investment ₹14,750
DRHP Draft Prospectus -
RHP Draft Prospectus -
Analysis

IPO Snapshot & Investor Takeaways

At the upper end of its price band, Manipal Health Enterprises is priced at ₹590 per share. With a minimum lot size of 25 shares, a retail investor applying for one lot would need approximately ₹14,750 to participate in this Mainboard issue.

The latest recorded Grey Market Premium for Manipal Health Enterprises stands at ₹6, implying an estimated listing gain of around 1.02% over the issue price if it holds until listing. This is down ₹4 from its previously recorded level. GMP reflects informal grey-market sentiment rather than a guaranteed outcome, and can change at any point until the day of listing.

As of the latest update, Manipal Health Enterprises's IPO was subscribed 4.92x overall, with a category-wise breakdown of Retail 0.93x, QIB 8.25x.

Among the strengths highlighted in Manipal Health Enterprises's IPO documents: A large network of multi-speciality hospitals supported by a wide base of doctors.; Focus on high-end specialities like cardiac, oncology and neurosciences, driving revenue..

Investors should also weigh the risk factors Manipal Health Enterprises has disclosed, including: High dependence on insurance and third-party administrators for revenue..

A share of Manipal Health Enterprises's issue proceeds is earmarked for Repayment Of Borrowings: 5378 (67.23%).

Mainboard IPOs list on the main platform of BSE/NSE, typically involve larger issue sizes, and draw participation across retail, HNI and institutional (QIB) investor categories.

Timeline

IPO roadmap at a glance

✓
Bidding Opens 29 Jul 2026
✓
Bidding Closes 31 Jul 2026
03
Allotment Next 03 Aug 2026
04
Listing 05 Aug 2026
Grey Market Premium

Daily GMP status

Date GMP Change Gain
31 Jul 2026 ₹6.00 -₹4.00 1.02%
30 Jul 2026 ₹10.00 - 1.69%
Swipe to see more →
Market Lot

Application size breakdown

Category Lots Shares Amount
Retail Minimum 1 Lot 25 ₹14,750
Retail Maximum 13 Lot 325 ₹1,91,750
S-HNI Minimum 14 Lot 350 ₹2,06,500
S-HNI Maximum 67 Lot 1,675 ₹9,88,250
B-HNI Minimum 68 Lot 1,700 ₹10,03,000
Swipe to see more →
Fund Utilization

Objects of the Issue & Official Documents

  • Repayment Of Borrowings 5378 (67.23%)
  • General Corporate Purpose 2048 (25.59%)
Issue Notes

Important takeaways before applying

Strengths

  • A large network of multi-speciality hospitals supported by a wide base of doctors.
  • Focus on high-end specialities like cardiac, oncology and neurosciences, driving revenue.
  • Strong presence across key regions with ongoing expansion plans.
  • Significant share of revenue from insurance and institutional payors.
  • Established track record of growth in patient volumes and operations.

Risks

  • High dependence on insurance and third-party administrators for revenue.
  • Delays in payments from government schemes can impact cash flows.
  • Expansion into new regions may face operational and market challenges.
  • Failure to attract sufficient patients can lead to underutilised capacity.
  • High outstanding receivables may affect working capital and liquidity.
Analysis

Manipal Health IPO Reservation

The Manipal Health IPO follows the SEBI-prescribed allocation structure for a Book Build Issue. The issue is divided among Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), Retail Individual Investors (RIIs), and Anchor Investors. This allocation framework is designed to ensure broad participation from institutional as well as retail investors.

The category-wise reservation below shows the percentage of shares reserved for each investor segment. The final allotment in every category will depend on the subscription received and the basis of allotment approved after the IPO closes.

Investor Category Shares Offered Reservation (%)
Anchor Investor – Shares -%
QIB (Ex. Anchor) – Shares 75%
NII Shares Offered – Shares 15%
Retail Shares Offered – Shares 10%
Note: The exact number of shares reserved for each category, including the Anchor Investor portion, will be updated once the company announces the final allocation before the IPO opens.
Analysis

Manipal Health IPO Anchor Investors

Manipal Health Limited has scheduled the Anchor Investor Bidding on July 28, 2026, one working day before the IPO opens for public subscription. The anchor book is reserved for Qualified Institutional Buyers (QIBs) and is intended to gauge institutional demand ahead of the public issue.

The company will announce the names of participating anchor investors, the total anchor allocation, and the issue size after the completion of the anchor bidding process. The allotted anchor shares will remain subject to the applicable SEBI lock-in requirements.

Particular Details
Anchor Bidding Date July 28, 2026
Anchor Investors List PDF
Shares Offered [.] Shares
Anchor Issue Size [.] Cr.
Lock-in Period End Date (50% Shares – 30 Days) 2026
Lock-in Period End Date (Remaining 50% Shares – 90 Days) 2026
Note: The anchor investor allocation, issue size, lock-in end dates, and investor list will be updated after the completion of the anchor book allocation and the company's official announcement.
Analysis

Manipal Health Enterprises IPO Dates

Particular Dates
IPO Open Date 29 Jul 2026
IPO Close Date 31 Jul 2026
Basis of Allotment 03 Aug 2026
Refunds -
Credit to Demat Account -
IPO Listing Date 05 Aug 2026

Note: The timeline for Manipal Health Enterprises IPO is tentative and subject to change.

Analysis

Manipal Health IPO Promoters and Holding Pattern

Manipal Health Enterprises Limited is promoted by Dr. Ranjan Ramdas Pai, Manipal Global Health Services, Memg International Ltd., Kangto Investments Pte. Ltd., Imperius Healthcare Investments Pte. Ltd., and Kabru Investments Pte. Ltd.. The promoter group has played a significant role in establishing and expanding one of India's leading multi-specialty healthcare and hospital networks.

Following the completion of the IPO, the promoters will continue to hold a substantial stake in the company. However, the final post-issue promoter shareholding percentage will be confirmed after the completion of the IPO process and the allotment of shares.

Particular Shares % Share
Promoter Holding Pre Issue 1,17,97,57,321 81.43%
Promoter Holding Post Issue 1,31,53,50,541 -%
Note: The final post-issue promoter shareholding percentage will be updated after the IPO allotment is completed and the company's post-listing shareholding pattern is officially disclosed.
Analysis

Manipal Health Enterprises Objects of the Issue & Utilisation of Proceeds

To Be Updated Soon

Analysis

Manipal Health About IPO


Manipal Health Enterprises Limited is a healthcare company in India that runs many hospitals, clinics, and diagnostic centres. It is part of the Manipal Group, which was started by T. M. A. Pai.


Moreover, the company provides different types of medical services such as organ transplants, oncology, cardiology, neurology, orthopaedics, and preventive healthcare.


The company has a major of give good quality care to patients and make healthcare more available. As of September 30, 2025, the company runs 38 hospitals (or 48 hospitals on a pro forma basis) with 10,761 beds (or 12,367 licensed beds on a pro forma basis). It also operates 17 clinics. 

Analysis

Manipal Health Enterprises Company Financials

To Be Updated Soon

Analysis

Manipal Health Enterprises Company Valuation – FY2026

To Be Updated Soon

Analysis

Manipal Health Enterprises IPO Peer Group Comparison

To Be Updated Soon

Analysis

IPO Lead Managers aka Merchant Bankers

  • Kotak Mahindra Capital Company Limited
  • Axis Capital Limited
  • Goldman Sachs (India) Securities Private Limited
  • Jefferies India Private Limited
  • J.P. Morgan India Private Limited
  • UBS Securities India Private Limited
  • DBS Bank India Limited
Comparison

Compare Manipal Health Enterprises IPO with similar IPOs

FAQ

Manipal Health Enterprises IPO FAQs

Manipal Health Enterprises IPO GMP today is Rs 6. Investors can use this GMP along with price band and subscription status for a better IPO review.
Manipal Health Enterprises IPO price band is Rs 560.00 to Rs 590.00. Check the latest issue price, lot size and GMP together before applying.
Manipal Health Enterprises IPO open date is 29 Jul 2026, close date is 31 Jul 2026, and listing date is 05 Aug 2026.
Manipal Health Enterprises IPO lot size is 25 shares. The minimum retail investment is Rs 14,750.
Manipal Health Enterprises is classified as a Mainboard IPO. This helps investors quickly understand the issue category and exchange segment.
Manipal Health Enterprises IPO subscription status currently shows Retail 0.93x, QIB 8.25x, Overall 4.92x.
Manipal Health Enterprises Limited is a healthcare service provider engaged in running and managing hospitals, clinics and diagnostic centres, primarily in India. It operates a network of multi-speciality hospitals offering clinical services across several specialities, with a focus on tertiary and quaternary care such as cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics and renal sciences. The company serves patients through inpatient and outpatient services, generating revenue from healthcare services paid by patients directly, insurance and third-party administrators, government schemes and corporate arrangements. Its network includes multiple hospitals supported by a large pool of doctors, and it caters to a significant volume of patients across its facilities. The company operates as a single business segment focused on medical and healthcare services, combining hospital infrastructure, clinical expertise and diagnostic capabilities to deliver care.
Manipal Health Enterprises IPO issue size is TBA and the expected allotment date is 03 Aug 2026.
Community discussion

Comments

Share a useful question or insight about Manipal Health Enterprises.

Loading comments...

Leave a comment

Your email address will not be published. All comments and replies are reviewed before appearing.

Related Topics
Manipal Health Enterprises IPOManipal Health Enterprises GMPManipal Health Enterprises IPO GMPManipal Health Enterprises IPO GMP todayManipal Health Enterprises grey market premiumManipal Health Enterprises price bandManipal Health Enterprises subscription statusManipal Health Enterprises allotment statusManipal Health Enterprises listing dateManipal Health Enterprises lot sizeManipal Health Enterprises IPO reviewManipal Health Enterprises IPO listing gain estimateManipal Health Enterprises GMP calculatorManipal Health Enterprises IPO 2026